REGENERON PHARMACEUTICALS, INC.

(REGN)
  Report
Real-time Estimate Cboe BZX  -  05/27 09:35:31 am EDT
682.20 USD   -0.18%
09:17aInovio Pharmaceuticals Says Brain Cancer Combination Therapy Produced Immune Response in Phase 1/2 Trial
MT
05/23SVB Securities Initiates Regeneron Pharmaceuticals at Outperform with $738 Price Target
MT
05/23Fda approves dupixent (dupilumab) as first treatment for adults and children aged 12 and older with eosinophilic esophagitis
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
All news about REGENERON PHARMACEUTICALS, INC.
09:17aInovio Pharmaceuticals Says Brain Cancer Combination Therapy Produced Immune Response i..
MT
05/23SVB Securities Initiates Regeneron Pharmaceuticals at Outperform with $738 Price Target
MT
05/23Fda approves dupixent (dupilumab) as first treatment for adults and children aged 12 an..
AQ
05/23Evkeeza (evinacumab) phase 3 trial demonstrates 48% ldl-c reduction in children with ul..
AQ
05/23FDA approves Dupixent« (dupilumab) as first treatment for adults and children aged 12 ..
AQ
05/23SVB Securities Initiates Regeneron Pharmaceuticals at Outperform With $738 Price Target
MT
05/23Regeneron's Phase 3 Trial Data Shows Positive Results for Potential Treatment of Rare H..
MT
05/21Evkeeza« (evinacumab) Phase 3 Trial Demonstrates 48% LDL-C Reduction in Children with U..
PR
05/20Regeneron, Sanofi Receive US FDA Approval of Dupixent for Eosinophilic Esophagitis
MT
05/20Sanofi's Dupixent wins U.S. approval for bigger use
RE
05/20FDA Grants Regeneron Approval for Dupixent in Inflammatory Disorder Treatment
DJ
05/17Vyriad, Inc. Raises $29.5M in Series B Funding Led by Renowned Genetics Entrepreneur
PR
05/16Regeneron Pharmaceuticals, Inc. - HIGH SCHOOL SCIENTISTS FROM AROUND THE WORLD WIN NEAR..
AQ
05/13High School Scientists from Around the World Win Nearly $8M in Awards, Scholarships at ..
PR
05/13High School Scientists from Around the World Win Nearly $8M in Awards, Scholarships at ..
PR
05/10TRANSCRIPT : Regeneron Pharmaceuticals, Inc. Presents at Bank of America 2022 Healthcare C..
CI
05/05RBC Capital Adjusts Regeneron Pharmaceuticals Price Target to $658 From $647, Maintains..
MT
05/04Regeneron's COVID drug sales outside U.S. help revenue beat
RE
05/04GLOBAL MARKETS LIVE : Airbnb, Pandora, Apple, Twitter, Meta...
05/04WALL STREET STOCK EXCHANGE : Finally, it's time for Powell's speech
05/04TRANSCRIPT : Regeneron Pharmaceuticals, Inc., Q1 2022 Earnings Call, May 04, 2022
CI
05/04US Futures Higher Ahead of Fed Funds Rate Announcement, National Employment Report
MT
05/04REGENERON PHARMACEUTICALS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL COND..
AQ
05/04Tranche Update on Regeneron Pharmaceuticals, Inc.'s Equity Buyback Plan announced on No..
CI
05/04Regeneron Pharmaceuticals Posts Higher Q1 Earnings, Revenue
MT
05/04REGENERON : Q1 Earnings Snapshot
AQ
05/04Regeneron quarterly profit drops as COVID antibody sales hit
RE
05/04Earnings Flash (REGN) REGENERON PHARMACEUTICALS Reports Q1 Revenue $2.97B, vs. Street E..
MT
05/04Earnings Flash (REGN) REGENERON PHARMACEUTICALS Reports Q1 EPS $11.49, vs. Street Est o..
MT
05/04Regeneron Reports First Quarter 2022 Financial and Operating Results
PR
05/02Regeneron Announces Investor Conference Presentations
PR
05/02RBC Cuts Price Target on Regeneron Pharmaceuticals to $647 From $679, Maintains Sector ..
MT
04/28Sanofi Confident In Full-Year Prospects As Dupixent, Consumer Healthcare Drive Strong F..
MT
04/28Sanofi profit gain beats market view on bestseller drug Dupixent
RE
04/19SECTOR UPDATE : Health Care Stocks Carried Higher in Rising Tuesday Markets
MT
04/19SECTOR UPDATE : Health Care Stocks Carried Higher in Rising Tuesday Markets
MT
04/19Top Midday Gainers
MT
04/19SECTOR UPDATE : Health Care
MT
04/19Checkmate Pharmaceuticals Shares Take Flight on Regeneron Deal
DJ
04/19SECTOR UPDATE : Health Care Stocks Mixed Pre-Bell Tuesday
MT
04/19SECTOR UPDATE : Health Care
MT
04/19Regeneron to Buy Checkmate Pharmaceuticals for About $250 Million
DJ
04/19Regeneron Pharmaceuticals Agrees to Buy Checkmate Pharmaceuticals in $250 Million All-C..
MT
04/19SpringWorks Therapeutics, Regeneron Collaborate to Test Multiple Myeloma Combination Th..
MT
04/19SpringWorks Therapeutics Announces Clinical Trial Collaboration and Supply Agreement wi..
CI
04/19Regeneron Pharmaceuticals, Inc. entered into a definitive agreement to acquire Checkmat..
CI
04/15FDA Accepts Regeneron And Sanofi's DUPIXENT (Dupilumab) SBLA For Priority Review
AQ
04/14Regeneron Pharmaceuticals' Biologics License Application Review for COVID-19 Treatment ..
MT
04/14U.S. FDA delays decision on Regeneron/Roche COVID antibody therapy
RE
04/14U.S. FDA Extends Review of Biologics License Application for REGEN-COV« (casirivimab an..
PR
04/14Regeneron Pharmaceuticals, Inc. Announces U.S. FDA Extends Review of Biologics License ..
CI
04/14FDA Extends Review of Regeneron's REGEN-COV Covid-19 Drug
DJ
04/13WALL STREET STOCK EXCHANGE : The confusion over inflation
04/13ANALYST RECOMMENDATIONS : CarMax, Boeing, JetBlue, Medtronic, PepsiCo...
04/12Morgan Stanley Adjusts Regeneron Pharmaceuticals Price Target to $632 From $605, Mainta..
MT
04/12Barclays Adjusts Price Target for Regeneron Pharmaceuticals to $745 From $700, Maintain..
MT
04/12INSIDER SELL : Regeneron Pharmaceuticals
MT
04/11INSIDER SELL : Regeneron Pharmaceuticals
MT
04/11INSIDER SELL : Regeneron Pharmaceuticals
MT
04/08Regeneron - dupixent approved by european commission for children aged 6 to 11 years wi..
AQ
04/07INSIDER SELL : Regeneron Pharmaceuticals
MT
04/07GLOBAL MARKETS LIVE : Airbus, Berkshire Hathaway, Meta, Samsung, Tesla...
04/07WALL STREET STOCK EXCHANGE : What's in store for investors in 2022?
04/07Regeneron Pharmaceuticals, Sanofi Say EC Expands Dupixent's Marketing Approval to Treat..
MT
04/06ViGeneron GmbH Signs Gene Therapy Strategic Collaboration and Option Agreement with Reg..
CI
04/05Regeneron to Report First Quarter 2022 Financial and Operating Results and Host Confere..
PR
04/04INSIDER SELL : Regeneron Pharmaceuticals
MT
04/04INSIDER SELL : Regeneron Pharmaceuticals
MT
04/04FDA accepts Dupixent« (dupilumab) for Priority Review in patients aged 12 years and ol..
AQ
04/04Regeneron Pharmaceuticals, Sanofi's Dupixent Gets FDA Priority Review for Treatment of ..
MT
04/04FDA Accepts Dupixent« (dupilumab) for Priority Review in Patients Aged 12 Years and Old..
PR
04/04Regeneron Pharmaceuticals, Inc. and Sanofi Announce FDA Accepts Dupixent« for Priority ..
CI
04/01INSIDER SELL : Regeneron Pharmaceuticals
MT
04/01INSIDER SELL : Regeneron Pharmaceuticals
MT
04/01CASE LAW : A Review Of Selected Pharmaceutical Patents In The UK Courts During 2020
AQ
1  2  3  4  5  6  7  8  9  10Next
Official Publications
02/04SEC Filing 8K 
02/04Annual results 
02/01SEC Filing 8K 
02/01Report 
02/01Report 
01/10SEC Filing 8K 
Upcoming event on REGENERON PHARMACEUTICALS, INC.